Identifying HIV-1 dual infections

Retrovirology

Volumn 4, Issue , 2007, Pages

  van der Kuyl, Antoinette C ^a   Cornelissen, Marion ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RNA;

ANTIBIOTIC RESISTANCE; CD4+ T LYMPHOCYTE; CYTOMEGALOVIRUS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FOLLOW UP; GENOTYPE; HETERODUPLEX ANALYSIS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE COUNT; MEDICAL RESEARCH; PATIENT SELECTION; REVIEW; RNA VIRUS; SEROTYPING; SEXUAL BEHAVIOR; SUPERINFECTION; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; CLASSIFICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

HIV INFECTIONS; HIV-1; HUMANS; SUPERINFECTION;

EID: 35648988965     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-4-67     Document Type: Review

References (103)

1. Roest RW Carman WF Maertzdorf J Scoular A Harvey J Kant M Van Der Meijden WI Verjans GM Osterhaus AD Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes J Med Virol 2004, 73:601-604. 10.1002/jmv.20132 15221906
2. Roest RW Maertzdorf J Kant M Van Der Meijden WI Osterhaus AD Verjans GM High incidence of genotypic variance between sequential herpes simplex virus type 2 isolates from HIV-1-seropositive patients with recurrent genital herpes J Infect Dis 2006, 194:1115-1118. 10.1086/507683 16991086
3. Van Baarle D Hovenkamp E Kersten MJ Klein MR Miedema F Van Oers MH Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: No association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma Blood 1999, 93:3949-3955. 10339504
4. Quinlivan M Breuer J Molecular studies of Varicella zoster virus Rev Med Virol 2006, 16:225-250. 10.1002/rmv.502 16791838
5. Drew WL Sweet ES Miner RC Mocarski ES Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization J Infect Dis 1984, 150:952-953. 6094678
6. Spector SA Hirata KK Newman TR Identification of multiple cytomegalovirus strains in homosexual men with acquired immunodeficiency syndrome J Infect Dis 1984, 150:953-956. 6094679
7. Bale JF Jr. Petheram SJ Souza IE Murph JR Cytomegalovirus reinfection in young children J Pediatr 1996, 128:347-352. 10.1016/ S0022-3476(96)70279-2 8774502
8. Beyari MM Hodgson TA Cook RD Kondowe W Molyneux EM Scully CM Teo CG Porter SR Multiple human herpesvirus-8 infection J Infect Dis 2003, 188:678-689. 10.1086/377504 12934184
9. Kao JH Chen PJ Lai MY Chen DS Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus Hepatology 2001, 34:817-823. 10.1053/jhep.2001.28188 11584381
10. Blackard JT Sherman KE Hepatitis C virus coinfection and superinfection J Infect Dis 2007, 195:519-524. 10.1086/510858 17230411
11. Caterino-de-Araujo A Favero A los Santos-Fortuna E Suleiman J Chieco-Bianchi L Calabro ML HTLV-I/HTLV-II coinfection in an AIDS patient from Sao Paulo, Brazil AIDS Res Hum Retroviruses 2000, 16:715-719. 10.1089/088922200308710 10826478
12. Cot MC Poulain M Delagneau JF Peeters M Brun-Vezinet F Dual HIV-1 and HIV-2 infection in West Africa supported by synthetic peptide analysis AIDS Res Hum Retroviruses 1988, 4:239-241. 3207511
13. Evans LA Moreau J Odehouri K Seto D Thomson-Honnebier G Legg H Barboza A Cheng-Mayer C Levy JA Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient Lancet 1988, 2:1389-1391. 10.1016/S0140-6736(88)90586-7 2904524
14. George JR Ou CY Parekh B Brattegaard K Brown V Boateng E De Cock KM Prevalence of HIV-1 and HIV-2 mixed infections in Cote d'Ivoire Lancet 1992, 340:337-339. 10.1016/0140-6736(92)91406-X 1353806
15. Nkengasong JN Kestens L Ghys PD Koblavi-Deme S Otten RA Bile C Maurice C Kalou M Laga M Wiktor SZ Greenberg AE Dual infection with human immunodeficiency virus type 1 and type 2: Impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast AIDS Res Hum Retroviruses 2000, 16:1371-1378. 10.1089/08892220050140919 11018856
16. Gottlieb GS Sow PS Hawes SE Ndoye I Coll-Seck AM Curlin ME Critchlow CW Kiviat NB Mullins JI Molecular epidemiology of dual HIV-1/HIV-2 seropositive adults from Senegal, West Africa AIDS Res Hum Retroviruses 2003, 19:575-584. 10.1089/088922203322230941 12908935
17. Nethe M Berkhout B van der Kuyl AC Retroviral superinfection resistance Retrovirology 2005, 2:52. 1224871 16107223 10.1186/1742-4690-2-52
18. Ramos A Hu DJ Nguyen L Phan KO Vanichseni S Promadej N Choopanya K Callahan M Young NL McNicholl J Mastro TD Folks TM Subbarao S Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users J Virol 2002, 76:7444-7452. 136380 12097556 10.1128/ JVI.76.15.7444-7452.2002
19. Jost S Bernard MC Kaiser L Yerly S Hirschel B Samri A Autran B Goh LE Perrin L A patient with HIV-1 superinfection N Engl J Med 2002, 347:731-736. 10.1056/NEJMoa020263 12213944
20. Altfeld M Allen TM Yu XG Johnston MN Agrawal D Korber BT Montefiori DC O'Connor DH Davis BT Lee PK Maier EL Harlow J Goulder PJ Brander C Rosenberg ES Walker BD HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus Nature 2002, 420:434-439. 10.1038/nature01200 12459786
21. Smith DM Richman DD Little SJ HIV Superinfection J Infect Dis 2005, 192:438-444. 10.1086/431682 15995957
22. Plantier JC Lemee V Dorval I Gueudin M Braun J Hutin P Ruffault A Simon F HIV-1 group M superinfection in an HIV-1 group O-infected patient AIDS 2004, 18:2444-2446. 15622327
23. Yang OO Daar ES Jamieson BD Balamurugan A Smith DM Pitt JA Petropoulos CJ Richman DD Little SJ Brown AJ Human immunodeficiency virus type 1 clade B superinfection: Evidence for differential immune containment of distinct clade B strains J Virol 2005, 79:860-868. 538553 15613314 10.1128/JVI.79.2.860-868.2005
24. van der Kuyl AC Kozaczynska K Van den Burg R Zorgdrager F Back N Jurriaans S Berkhout B Reiss P Cornelissen M Triple HIV-1 infection New England Journal of Medicine 2005, 352:2557-2559. 10.1056/ NEJM200506163522420 15958817
25. Pernas M Casado C Fuentes R Perez-Elias MJ Lopez-Galindez C A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection J Acquir Immune Defic Syndr 2006, 42:12-18. 10.1097/ 01.qai.0000214810.65292.73 16763489
26. Smith DM Wong JK Hightower GK Ignacio CC Koelsch KK Petropoulos CJ Richman DD Little SJ HIV drug resistance acquired through superinfection AIDS 2005, 19:1251-1256. 16052079
27. Blick G Kagan RM Coakley E Petropoulos C Maroldo L Greiger-Zanlungo P Gretz S Garton T The Probable Source of Both the Primary Multidrug-Resistant (MDR) HIV-1 Strain Found in a Patient with Rapid Progression to AIDS and a Second Recombinant MDR Strain Found in a Chronically HIV-1-Infected Patient J Infect Dis 2007, 195:1250-1259. 10.1086/512240 17396993
28. McCutchan FE Hoelscher M Tovanabutra S Piyasirisilp S Sanders-Buell E Ramos G Jagodzinski L Polonis V Maboko L Mmbando D Hoffmann O Riedner G von Sonnenburg F Robb M Birx DL In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: Evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection J Virol 2005, 79:11693-11704. 1212589 16140747 10.1128/JVI.79.18.11693-11704.2005
29. Gottlieb GS Nickle DC Jensen MA Wong KG Kaslow RA Shepherd JC Margolick JB Mullins JI HIV type 1 superinfection with a dual-tropic virus and rapid progression to AIDS: A case report Clin Infect Dis 2007, 45:501-509. 10.1086/520024 17638203
30. Smith DM Wong JK Hightower GK Ignacio CC Koelsch KK Daar ES Richman DD Little SJ Incidence of HIV superinfection following primary infection JAMA 2004, 292:1177-1178. 10.1001/jama.292.10.1177 15353529
31. Yerly S Jost S Monnat M Telenti A Cavassini M Chave JP Kaiser L Burgisser P Perrin L HIV-1 co/super-infection in intravenous drug users AIDS 2004, 18:1413-1421. 10.1097/01.aids.0000131330.28762.0c 15199317
32. Hu DJ Subbarao S Vanichseni S Mock PA Ramos A Nguyen L Chaowanachan T Griensven F Choopanya K Mastro TD Tappero JW Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand AIDS 2005, 19:303-308. 15718841
33. Chohan B Lavreys L Rainwater SM Overbaugh J Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype J Virol 2005, 79:10701-10708. 1182664 16051862 10.1128/ JVI.79.16.10701-10708.2005
34. Manigart O Courgnaud V Sanou O Valea D Nagot N Meda N Delaporte E Peeters M Van de PP HIV-1 superinfections in a cohort of commercial sex workers in Burkina Faso as assessed by an autologous heteroduplex mobility procedure AIDS 2004, 18:1645-1651. 10.1097/ 01.aids.0000131333.30548.db 15280775
35. Lamine A Caumont-Sarcos A Chaix ML Saez-Cirion A Rouzioux C Delfraissy JF Pancino G Lambotte O Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study) AIDS 2007, 21:1043-1045. 10.1097/QAD.0b013e3280d5a7ac 17457100
36. Takehisa J Zekeng L Miura T Ido E Yamashita M Mboudjeka I Gurtler LG Hayami M Kaptue L Triple HIV-1 infection with group O and Group M of different clades in a single Cameroonian AIDS patient J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:81-82. 8989217
37. Takehisa J Zekeng L Ido E Yamaguchi-Kabata Y Mboudjeka I Harada Y Miura T Kaptu L Hayami M Human immunodeficiency virus type 1 intergroup (M/O) recombination in cameroon J Virol 1999, 73:6810-6820. 112766 10400779
38. Gerhardt M Mloka D Tovanabutra S Sanders-Buell E Hoffmann O Maboko L Mmbando D Birx DL McCutchan FE Hoelscher M In-depth, longitudinal analysis of viral quasispecies from an individual triply infected with late-stage human immunodeficiency virus type 1, using a multiple PCR primer approach Journal of Virology 2005, 79:8249-8261. 1143736 15956571 10.1128/JVI.79.13.8249-8261.2005
39. Kozaczynska K Cornelissen M Reiss P Zorgdrager F van der Kuyl AC HIV-1 sequence evolution in vivo after superinfection with three viral strains Retrovirology 2007, 4:59. 10.1186/1742-4690-4-59 17716368
40. Chakraborty B Valer L De Mendoza C Soriano V Quinones-Mateu ME Failure to detect human immunodeficiency virus type 1 superinfection in 28 HIV-seroconcordant individuals with high risk of reexposure to the virus AIDS Res Hum Retroviruses 2004, 20:1026-1031. 10.1089/aid.2004.20.1026 15585092
41. Koelsch KK Smith DM Little SJ Ignacio CC Macaranas TR Brown AJ Petropoulos CJ Richman DD Wong JK Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus AIDS 2003, 17:F11-F16. 10.1097/00002030-200305020-00001 12700477
42. Brenner B Routy JP Quan Y Moisi D Oliveira M Turner D Wainberg MA Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection AIDS 2004, 18:1653-1660. 10.1097/ 01.aids.0000131377.28694.04 15280776
43. Burke DS Recombination in HIV: An important viral evolutionary strategy Emerg Infect Dis 1997, 3:253-259. 9284369
44. Najera R Delgado E Perez-Alvarez L Thomson MM Genetic recombination and its role in the development of the HIV-1 pandemic AIDS 2002, 16(Suppl 4):S3-16. 12698994
45. Charpentier C Nora T Tenaillon O Clavel F Hance AJ Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients J Virol 2006, 80:2472-2482. 1395372 16474154 10.1128/ JVI.80.5.2472-2482.2006
46. Rousseau CM Learn GH Bhattacharya T Nickle DC Heckerman D Chetty S Brander C Goulder PJ Walker BD Kiepiela P Korber BT Mullins JI Extensive intrasubtype recombination in South african human immunodeficiency virus type 1 subtype C infections J Virol 2007, 81:4492-4500. 1900147 17314156 10.1128/JVI.02050-06
47. Kalish ML Robbins KE Pieniazek D Schaefer A Nzilambi N Quinn TC St Louis ME Youngpairoj AS Phillips J Jaffe HW Folks TM Recombinant viruses and early global HIV-1 epidemic Emerg Infect Dis 2004, 10:1227-1234. 15324542
48. Anderson JP Rodrigo AG Learn GH Madan A Delahunty C Coon M Girard M Osmanov S Hood L Mullins JI Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E J Virol 2000, 74:10752-10765. 110950 11044120 10.1128/JVI.74.22.10752-10765.2000
49. Gross KL Porco TC Grant RM HIV-1 superinfection and viral diversity AIDS 2004, 18:1513-1520. 10.1097/01.aids.0000131361.75328.47 15238769
50. Taylor JE Korber BT HIV-1 intra-subtype superinfection rates: Estimates using a structured coalescent with recombination Infect Genet Evol 2005, 5:85-95. 10.1016/j.meegid.2004.07.001 15567142
51. Herbinger KH Gerhardt M Piyasirisilp S Mloka D Arroyo MA Hoffmann O Maboko L Birx DL Mmbando D McCutchan FE Hoelscher M Frequency of HIV type 1 dual infection and HIV diversity: Analysis of low- and high-risk populations in Mbeya Region, Tanzania AIDS Res Hum Retroviruses 2006, 22:599-606. 10.1089/aid.2006.22.599 16831083
52. Saldana J Elena SF Sole RV Coinfection and superinfection in RNA virus populations: A selection-mutation model Math Biosci 2003, 183:135-160. 10.1016/S0025-5564(03)00038-5 12711408
53. Carrillo FY Sanjuan R Moya A Cuevas JM The effect of co- and superinfection on the adaptive dynamics of vesicular stomatitis virus Infect Genet Evol 2007, 7:69-73. 10.1016/j.meegid.2006.04.004 16807134
54. Smith DM Strain MC Frost SD Pillai SK Wong JK Wrin T Liu Y Petropolous CJ Daar ES Little SJ Richman DD Lack of neutralizing antibody response to HIV-1 predisposes to superinfection Virology 2006, 355:1-5 10.1016/ j.virol.2006.08.009 16962152
55. Kono Y Fukunaga Y Kobayashi K Resistance of horses infected chronically with equine infectious anemia virus against reinfection Natl Inst Anim Health Q (Tokyo) 1973, 13:173-181 4792269
56. Issel CJ Horohov DW Lea DF Adams WV Jr. Hagius SD McManus JM Allison AC Montelaro RC Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus J Virol 1992, 66:3398-3408 241120 1316455
57. Liu SL Schacker T Musey L Shriner D McElrath MJ Corey L Mullins JI Divergent patterns of progression to AIDS after infection from the same source: Human immunodeficiency virus type 1 evolution and antiviral responses J Virol 1997, 71:4284-4295 191644 9151816
58. Gottlieb GS Nickle DC Jensen MA Wong KG Grobler J Li F Liu SL Rademeyer C Learn GH Karim SS Williamson C Corey L Margolick JB Mullins JI Dual HIV-1 infection associated with rapid disease progression Lancet 2004, 363:619-622 10.1016/S0140-6736(04)15596-7 14987889
59. Jurriaans S Kozaczynska K Zorgdrager F Steingrover R Prins JM van der Kuyl AC Cornelissen M A sudden rise in viral load is infrequently associated with HIV-1 superinfection JAIDS 2007 in press
60. Grobler J Gray CM Rademeyer C Seoighe C Ramjee G Karim SA Morris L Williamson C Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers J Infect Dis 2004, 190:1355-1359 10.1086/423940 15346349
61. Casado C Pernas M Alvaro T Sandonis V Garcia S Rodriguez C Romero JD Grau E Ruiz L Lopez-Galindez C Coinfection and Superinfection in Patients with Long-Term, Nonprogressive HIV-1 Disease J Infect Dis 2007, 196:895-899 10.1086/520885 17703421
62. Peeters M Liegeois F Torimiro N Bourgeois A Mpoudi E Vergne L Saman E Delaporte E Saragosti S Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient J Virol 1999, 73:7368-7375 104263 10438826
63. Songok EM Lwembe RM Kibaya R Kobayashi K Ndembi N Kita K Vulule J Oishi I Okoth F Kageyama S Ichimura H Active generation and selection for HIV intersubtype A/D recombinant forms in a coinfected patient in Kenya AIDS Res Hum Retroviruses 2004, 20:255-258 10.1089/088922204773004996 15018715
64. Brand D Beby-Defaux A Mace M Brunet S Moreau A Godet C Jais X Cazein F Semaille C Barin F First identification of HIV-1 groups M and O dual infections in Europe AIDS 2004, 18:2425-2428 15622319
65. Vergne L Bourgeois A Mpoudi-Ngole E Mougnutou R Mbuagbaw J Liegeois F Laurent C Butel C Zekeng L Delaporte E Peeters M Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage Virology 2003, 310:254-266 12781713
66. Yamaguchi J Bodelle P Vallari AS Coffey R McArthur CP Schochetman G Devare SG Brennan CA HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections AIDS Res Hum Retroviruses 2004, 20:944-957 10.1089/ aid.2004.20.944 15585082
67. Barin F Plantier JC Brand D Brunet S Moreau A Liandier B Thierry D Cazein F Lot F Semaille C Desenclos JC Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic J Med Virol 2006, 78(Suppl 1):S13-S18 10.1002/ jmv.20600 16622871
68. Rodes B Toro C Jimenez V Soriano V Viral response to antiretroviral therapy in a patient coinfected with HIV type 1 and type 2 Clin Infect Dis 2005, 41:e19-e21 10.1086/431204 15983906
69. Murphy G Belda FJ Pau CP Clewley JP Parry JV Discrimination of subtype B and non-subtype B strains of human immunodeficiency virus type 1 by serotyping: Correlation with genotyping J Clin Microbiol 1999, 37:1356-1360 84775 10203486
70. Gaywee J Artenstein AW VanCott TC Trichavaroj R Sukchamnong A Amlee P De Souza M McCutchan FE Carr JK Markowitz LE Michael R Nittayaphan S Correlation of genetic and serologic approaches to HIV-1 subtyping in Thailand J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13:392-396 8948379
71. Barlow KL Green J Clewley JP Viral genome characterisation by the heteroduplex mobility and heteroduplex tracking assays Rev Med Virol 2000, 10:321-335 10.1002/1099-1654(200009/ 10)10:5<321::AID-RMV288>3.0.CO;2-X 11015743
72. Courgnaud V Seng R Becquart P Boulahtouf A Rouzioux C Boufassa F Deveau C Van de PP Meyer L Foulongne V HIV-1 co-infection prevalence in two cohorts of early HIV-1 seroconverters in France AIDS 2007, 21:1055-1056 10.1097/QAD.0b013e32810c8be1 17457105
73. Cornelissen M Jurriaans S Kozaczynska K Prins JM Hamidjaja RA Zorgdrager F Bakker M Back N van der Kuyl AC Routine HIV-1 genotyping as a tool to identify dual infections AIDS 2007, 21:807-811 10.1097/ QAD.0b013e3280f3c08a 17415035
74. International Union of Biochemistry and Molecular Biology 2007 http://www.iubmb.unibe.ch/
75. Hoelscher M Dowling WE Sanders-Buell E Carr JK Harris ME Thomschke A Robb ML Birx DL McCutchan FE Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay AIDS 2002, 16:2055-2064 10.1097/00002030-200210180-00011 12370505
76. Kijak GH Tovanabutra S Sanders-Buell E Watanaveeradej V de Souza MS Nelson KE Ketsararat V Gulgolgarn V Wera-arpachai M Sriplienchan S Khamboonrueng C Birx DL Robb ML McCutchan FE Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2 Virology 2007, 358:178-191 10.1016/j.virol.2006.07.055 16997343
77. Holder M Lewis PO Phylogeny estimation: Traditional and Bayesian approaches Nat Rev Genet 2003, 4:275-284 10.1038/nrg1044 12671658
78. McCormack GP Clewley JP The application of molecular phylogenetics to the analysis of viral genome diversity and evolution Rev Med Virol 2002, 12:221-238 10.1002/rmv.355 12125014
79. Hue S Clewley JP Cane PA Pillay D HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy AIDS 2004, 18:719-728 10.1097/00002030-200403260-00002 15075506
80. Sturmer M Preiser W Gute P Nisius G Doerr HW Phylogenetic analysis of HIV-1 transmission: Pol gene sequences are insufficient to clarify true relationships between patient isolates AIDS 2004, 18:2109-2113 10.1097/ 00002030-200411050-00002 15577643
81. Resik S Lemey P Ping LH Kouri V Joanes J Perez J Vandamme AM Swanstrom R Limitations to contact tracing and phylogenetic analysis in establishing HIV type 1 transmission networks in Cuba AIDS Res Hum Retroviruses 2007, 23:347-356 10.1089/aid.2006.0158 17411367
82. Hecht FM Wolf LE Lo B Lessons from an HIV transmission pair J Infect Dis 2007, 195:1239-1241 10.1086/512247 17396989
83. Titti F Sernicola L Geraci A Panzini G Di Fabio S Belli R Monardo F Borsetti A Maggiorella MT Koanga-Mogtomo M Corrias F Zamarchi R Amadori A Chieco-Bianchi L Verani P Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys J Gen Virol 1997, 78(Pt 10):2529-2539 9349474
84. Cranage MP Sharpe SA Whatmore AM Polyanskaya N Norley S Cook N Leech S Dennis MJ Hall GA In vivo resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose J Gen Virol 1998, 79(Pt 8)-1935-1944 9714241
85. Otten RA Ellenberger DL Adams DR Fridlund CA Jackson E Pieniazek D Rayfield MA Identification of a window period for susceptibility to dual infection with two distinct human immunodeficiency virus type 2 isolates in a Macaca nemestrina (pig-tailed macaque) model J Infect Dis 1999, 180:673-684 10.1086/314968 10438354
86. Sernicola L Corrias F Koanga-Mogtomo ML Baroncelli S Di Fabio S Maggiorella MT Belli R Michelini Z Macchia I Cesolini A Cioe L Verani P Titti F Long-lasting protection by live attenuated simian immunodeficiency virus in cynomolgus monkeys: No detection of reactivation after stimulation with a recall antigen Virology 1999, 256:291-302 10.1006/viro.1999.9652 10191194
87. Stebbings R Berry N Stott J Hull R Walker B Lines J Elsley W Brown S Wade-Evans A Davis G Cowie J Sethi M Almond N Vaccination with live attenuated simian immunodeficiency virus for 21 days protects against superinfection Virology 2004, 330:249-260 10.1016/j.virol.2004.09.026 15527850
88. Sharpe SA Cope A Dowall S Berry N Ham C Heeney JL Hopkins D Easterbrook L Dennis M Almond N Cranage M Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope J Gen Virol 2004, 85:2591-2602 10.1099/ vir.0.80050-0 15302953
89. Veazey RS DeMaria M Chalifoux LV Shvetz DE Pauley DR Knight HL Rosenzweig M Johnson RP Desrosiers RC Lackner AA Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection Science 1998, 280:427-431 10.1126/science.280.5362.427 9545219
90. Mattapallil JJ Douek DC Hill B Nishimura Y Martin M Roederer M Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection Nature 2005, 434:1093-1097 10.1038/nature03501 15793563
91. Li Q Duan L Estes JD Ma ZM Rourke T Wang Y Reilly C Carlis J Miller CJ Haase AT Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells Nature 2005, 434:1148-1152 15793562
92. Brenchley JM Schacker TW Ruff LE Price DA Taylor JH Beilman GJ Nguyen PL Khoruts A Larson M Haase AT Douek DC CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract J Exp Med 2004, 200:749-759 10.1084/jem.20040874 15365096
93. Guadalupe M Reay E Sankaran S Prindiville T Flamm J McNeil A Dandekar S Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy J Virol 2003, 77:11708-11717 229357 14557656 10.1128/JVI.77.21.11708-11717.2003
94. World Health Organization 2007 http://www.who.int
95. Tsui R Herring BL Barbour JD Grant RM Bacchetti P Kral A Edlin BR Delwart EL Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure J Virol 2004, 78:94-103 303392 14671091 10.1128/JVI.78.1.94-103.2004
96. Diaz RS Pardini R Catroxo M Operskalski EA Mosley JW Busch MP HIV-1 superinfection is not a common event J Clin Virol 2005, 33:328-330 10.1016/j.jcv.2004.11.021 16036183
97. Xiridou M van Griensven F Tappero JW Martin M Gurwith M Vanichseni S Kittikraisak W Coutinho R Choopanya K The Spread of HIV-1 Subtypes B and CRF01Æ Among Injecting Drug Users in Bangkok, Thailand J Acquir Immune Defic Syndr 2007 17496560
98. Gonzales MJ Delwart E Rhee SY Tsui R Zolopa AR Taylor J Shafer RW Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation J Infect Dis 2003, 188:397-405 10.1086/ 376534 12870121
99. McCutchan FE Global epidemiology of HIV J Med Virol 2006, 78(Suppl 1):S7-S12 10.1002/jmv.20599 16622870
100. Blackard JT Mayer KH HIV superinfection in the era of increased sexual risk-taking Sex Transm Dis 2004, 31:201-204 10.1097/ 01.OLQ.0000118082.45312.1F 15028931
101. Colfax GN Guzman R Wheeler S Mansergh G Marks G Rader M Buchbinder SP Beliefs about HIV reinfection (superinfection) and sexual behavior among a diverse sample of HIV-positive men who have sex with men J Acquir Immune Defic Syndr 2004, 36:990-992 10.1097/00126334-200408010-00017 15220710
102. Butler DM Smith DM Serosorting can potentially increase HIV transmissions AIDS 2007, 21:1218-1220 10.1097/QAD.0b013e32814db7bf 17502737
103. Elford J Bolding G Sherr L Hart G No evidence of an increase in serosorting with casual partners among HIV-negative gay men in London, 1998-2005 AIDS 2007, 21:243-245 17197819